... 10.1056/NEJMoa1814052. Slovenian Society of Cardiology, Matjaž Bunc; Spain ... EVIDoa2300067. https://doi.org/10.1056/EVIDoa2300067 and Standardization ...
#ACOD de nuevo, en este caso #apixabán
Mentions
Extended reach
Total likes
Video views
AI synopsis
Most discussions emphasize the trial's negative outcomes for apixaban, with phrases like 'prematurely stopped' and 'still a No Go' illustrating strong interpretations of its ineffectiveness; words like 'important work' and 'further evidence' reflect recognition of the study's high relevance and influence on clinical recommendations.
The majority of posts strongly support the conclusion that apixaban is ineffective and potentially harmful for patients with mechanical aortic valves, emphasizing the trial's findings and the need to rely on warfarin.
These discussions demonstrate high interest due to the serious implications of the trial results, highlighting the importance of anticoagulant choices for patients with mechanical valves.
Users actively analyze the research, referencing the trial, its premature termination, and broader implications, indicating moderate deep engagement.
The posts underscore a significant impact on clinical practice, with many highlighting the trial's influence on treatment guidelines and the ongoing debate about DOACs in this context.
#ACOD de nuevo, en este caso #apixabán
Gonna start a monthly tweet of: "Studies released this month that you need to read" - Apixaban v Warfarin for Mech Aortic Valve (https://t.co/dBpMgD6ZXG) - Hep C Updated Guidance (https://t.co/PmG8IUJzpr) - Early v Later Anticoag for Stroke w Afib (https://t.co/NtwrrUNrcG)
No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors for this important piece! Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/ouqI6gqmMe
Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al. https://t.co/XEcOJiGb9m #CardioTwitter #Afib
Is apixaban non-inferior to warfarin in patients with On-X mechanical aortic valves? Check out this infographic from #SCCMJC to learn more about the PROACT-Xa trial published in @NEJMEvidence! #PharmICU #SCCM https://t.co/yM7FCFgcG5 https://t.co/QDYpHoUKNV
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | @NEJMEvidence | @JHAlexanderMD @AndrewVekstein @IbrahimSultanMD et al. https://t.co/NqIzQZdyAl
Ref httpsevidencenejmorgdoi101056EVIDoa2300067 Join DOBBS and take part in our Journal Club httpsdobbsmyosr. The study compares apixaban and warfarin in patients with On-X mechanical aortic valves, showing apixaban's…
This episode explores the latest research on anticoagulant use in patients with On-X mechanical aortic valves, highlighting the failure of apixaban to match warfarin's efficacy and discussing implications for patient…
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/r8TFkYSG2d
RT @SCCM_CPP: Is apixaban non-inferior to warfarin in patients with On-X mechanical aortic valves? Check out this infographic from #SCCMJC…
Is apixaban non-inferior to warfarin in patients with On-X mechanical aortic valves? Check out this infographic from #SCCMJC to learn more about the PROACT-Xa trial published in @NEJMEvidence! #PharmICU #SCCM https://t.co/yM7FCFgcG5 https://t.co/QDYpHoUKNV
RT @SCCM_CPP: @SCCM @uc_health @jama @bswhealth @NEJM #SCCMJC #PharmICU Presenter 3: Priya Patel, PharmD @priya_patel98 PGY2 CC @Methodist…
@SCCM @uc_health @jama @bswhealth @NEJM #SCCMJC #PharmICU Presenter 3: Priya Patel, PharmD @priya_patel98 PGY2 CC @MethodistHosp will discuss Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve. @NEJM https://t.co/nrN4x8gAhf
@SCCM @uc_health @jama @bswhealth @NEJM #SCCMJC #PharmICU Presenter 3: Priya Patel, PharmD (@priya_patel98) PGY2 CC @MethodistHosp will discuss Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve. @NEJM https://t.co/nrN4x8gAhf
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
Warfarin Vs Apixaban
RT @MayoClinicCVS: Apixaban or warfarin in patients w/an On-X mechanical aortic valve? Experts including A. Pochettino, MD weigh in and sha…
RT @MayoClinicCVS: Apixaban or warfarin in patients w/an On-X mechanical aortic valve? Experts including A. Pochettino, MD weigh in and sha…
Apixaban or warfarin in patients w/an On-X mechanical aortic valve? Experts including A. Pochettino, MD weigh in and share their results in this #NEJM Evidence article. https://t.co/4sg0ID7IFC
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/Qd9DbfQ1me
RT @NEJMEvidence: ICYMI Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @TYWangMD et al. http…
RT @NEJMEvidence: ICYMI Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @TYWangMD et al. http…
RT @NEJMEvidence: ICYMI Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @TYWangMD et al. http…
RT @NEJMEvidence: ICYMI Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @TYWangMD et al. http…
ICYMI Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @TYWangMD et al. https://t.co/XEcOJiGb9m #CardioTwitter #Afib #ClinicalTrials @DCRInews @JHAlexanderMD @LarsSvenssonMD @CleClinicHVTI @ClevelandClinic @MyFranciscan
RT @AnticoagPharmD:
The highly anticipated PROACT-Xa trial comparing Apixaban vs Warfarin in patients who received newer generation On-X mechanical heart valve was prematurely terminated. Same fate as RE-ALIGN trial (Dabigatran vs Warfarin in mechanical heart valves). https://t.co/P67N9Mk6hb
DOACs for Mechanical Heart Valves : Still a No Go https://t.co/aghRRwK73Y
RT @sedar_es: #CardioToVascSEDAR
RT @ccfvascmed: https://t.co/XovyMaWT4e
https://t.co/XovyMaWT4e
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence #Epeeps @DrChaEP https://t.co/ytdEN8S5Lg
The correct answer is warfarin + aspirin. See PROACT Xa trial, published recently. DOI: 10.1056/EVIDoa2300067
RT @sedar_es: #CardioToVascSEDAR
#CardioToVascSEDAR
RT @KamGhadimiMD: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | @NEJMEvidence | @JHAlexanderMD @AndrewVekste…
RT @KamGhadimiMD: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | @NEJMEvidence | @JHAlexanderMD @AndrewVekste…
RT @NEJMEvidence: Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al.…
RT @KamGhadimiMD: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | @NEJMEvidence | @JHAlexanderMD @AndrewVekste…
RT @NEJMEvidence: Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al.…
RT @NEJMEvidence: Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al.…
RT @NEJMEvidence: Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al.…
RT @KamGhadimiMD: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | @NEJMEvidence | @JHAlexanderMD @AndrewVekste…
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | @NEJMEvidence | @JHAlexanderMD @AndrewVekstein @IbrahimSultanMD et al. https://t.co/NqIzQZdyAl
RT @NEJMEvidence: Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al.…
Gonna start a monthly tweet of: "Studies released this month that you need to read" - Apixaban v Warfarin for Mech Aortic Valve (https://t.co/dBpMgD6ZXG) - Hep C Updated Guidance (https://t.co/PmG8IUJzpr) - Early v Later Anticoag for Stroke w Afib (https://t.co/NtwrrUNrcG)
RT @NEJMEvidence: Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al.…
RT @NEJMEvidence: Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al.…
RT @NEJMEvidence: Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al.…
Original Article: “Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve,” by @JHAlexanderMD, MHS, et al. https://t.co/XEcOJiGb9m #CardioTwitter #Afib
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
Apixaban or Warfarin in Patients With an On-X Mechanical Aortic Valve. The trial was prematurely stopped owing to excess thromboembolic events in the apixaban group.
RT @CardioBornan: DOAC y Válvula mecánica
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @CardioBornan: DOAC y Válvula mecánica
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @CardioBornan: DOAC y Válvula mecánica
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @CardioBornan: DOAC y Válvula mecánica
RT @CardioBornan: DOAC y Válvula mecánica
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Tomas_MA_Cardio: Apixaban vs Warfarina en prótesis aorticas mecánicas. Nuevo fracaso para NOACs. ⬆️Tromboembolismo. ☑️Warfarina en casi…
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
RT @CardioBornan: DOAC y Válvula mecánica
RT @Felipediezhoyo: #ACOD de nuevo, en este caso #apixabán
#ACOD de nuevo, en este caso #apixabán
RT @CardioBornan: DOAC y Válvula mecánica
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve https://t.co/dNn80mhtPX
RT @CardioBornan: DOAC y Válvula mecánica
RT @gunnar_heine: Further Evidence for the 3 No's 4 NOACs PROACT Xa Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve…
Further Evidence for the 3 No's 4 NOACs PROACT Xa Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/ZIBHI7PjS6 (Illustation by Mark A. Crowther, Aubrey E. Jones and Daniel M. Witt) https://t.co/KlHWdk936J
RT @homam_heartdoc: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/CKjeocwZHk
RT @JudsonBWilliams: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence Kudos @RenatoDLopes1 and @Art…
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/2fahpAGblo
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence ダメだったかー https://t.co/eXHmJcUUo6
A question that needed to be answered. Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/4wVFzvc5AT
RT @JudsonBWilliams: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence Kudos @RenatoDLopes1 and @Art…
RT @homam_heartdoc: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/CKjeocwZHk
RT @JudsonBWilliams: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence Kudos @RenatoDLopes1 and @Art…
RT @adam_dr_: "Inhibition of factor Xa seems insufficient to prevent valve thrombosis or thromboembolism in patients with an On-X mechanica…
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence Kudos @RenatoDLopes1 and @ArtivionInc for this important work https://t.co/KhzWn2PJ5R
RT @homam_heartdoc: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/CKjeocwZHk
RT @homam_heartdoc: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/CKjeocwZHk
RT @roca_ferran: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve https://t.co/DS4nFbY2fZ
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
RT @homam_heartdoc: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/CKjeocwZHk
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve https://t.co/DS4nFbY2fZ
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/4u0xkcHjji
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/C9qP63N602
RT @homam_heartdoc: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/CKjeocwZHk
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
RT @homam_heartdoc: Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/CKjeocwZHk
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/tPZMngMviX
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/CKjeocwZHk
RT @adam_dr_: "Inhibition of factor Xa seems insufficient to prevent valve thrombosis or thromboembolism in patients with an On-X mechanica…
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
RT @adam_dr_: "Inhibition of factor Xa seems insufficient to prevent valve thrombosis or thromboembolism in patients with an On-X mechanica…
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
RT @adam_dr_: "Inhibition of factor Xa seems insufficient to prevent valve thrombosis or thromboembolism in patients with an On-X mechanica…
RT @adam_dr_: "Inhibition of factor Xa seems insufficient to prevent valve thrombosis or thromboembolism in patients with an On-X mechanica…
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
"Inhibition of factor Xa seems insufficient to prevent valve thrombosis or thromboembolism in patients with an On-X mechanical aortic valve." Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/m18fImkwxo
RT @md_arianemacedo: No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors…
No room for using DOACs in patients with mechanical aortic valves! Congrats @TYWangMD, @RenatoDLopes1, and all authors for this important piece! Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve | NEJM Evidence https://t.co/ouqI6gqmMe
... 10.1056/NEJMoa1814052. Slovenian Society of Cardiology, Matjaž Bunc; Spain ... EVIDoa2300067. https://doi.org/10.1056/EVIDoa2300067 and Standardization ...
https://doi.org/10.1056/evidoa2300067. cardiovascular anesthesiologists clinical practice 120. Douketis JD, Spyropolous AC, Murad MH, et al. Perioperative
https://doi.org/10.1056/evidoa2300067. cardiovascular anesthesiologists clinical practice 120. Douketis JD, Spyropolous AC, Murad MH, et al. Perioperative
EVIDoa2300067. https://doi.org/10.1056/EVIDoa2300067 comes in the COMPASS trial. Circulation 2019;139:1134–45. https://doi.org/10.1161/ 333. Guimarães HP ...
anticoagulation after acute ischaemic stroke with atrial fibrill- 2023,2(7): EVIDoa2300067. DOI: 10.1056/EVIDoa2300067. ation (OPTIMAS): a multicentre ...
doi.org/10.1056/EVIDoa2300067 valve implants. Eur Heart J. 2015;36(21):1297-1305. 6. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ...
NEJM Evid. 8. Li A, Garcia DA, Lyman GH, Carrier M. Direct oral anticoagulant 2023;2(7):EVIDoa2300067. doi:10.1056/evidoa2300067 (DOAC) versus low‐molecular ...
... EVIDoa2300067. https://doi.org/10.1056/EVIDoa2300067. You might also like. Tavi 150923155743 Lva1 App6892. PDF. 100% (1). Tavi 150923155743 Lva1 App6892. 157 ...
... 10.1056/EVIDoa2300067. Results: Apixaban did not demonstrate noninferiority to warfarin and is less effective than warfarin for the ...
... 10.1056/NEJMoa1300615 Apixaban or Warfarin in Patients with an On ... org/doi/full/10.1056/EVIDoa2300067 - Rheumatic AF Rivaroxaban in ...
2023; doi:10.1056/EVIDoa2300067. 相关. 主动脉瓣反流 · 主动脉瓣反流 · 主动脉瓣狭窄 · 主动脉瓣狭窄 · 主动脉瓣疾病 · 儿童主动脉瓣修复 · 微创心脏 ...
Wang TY, et al. Apixaban or warfarin in patients with an ON-X mechanical aortic valve. NEJM Evidence. 2023; doi:10.1056/EVIDoa2300067. 相关.
Wang TY, et al. Apixaban or warfarin in patients with an ON-X mechanical aortic valve. NEJM Evidence. 2023; doi:10.1056/EVIDoa2300067. 相关.
Apixaban or warfarin in patients with an ON-X mechanical aortic valve. NEJM Evidence. 2023; doi:10.1056/EVIDoa2300067. ذات صلة. ارتجاع الصمام ...
2023; doi:10.1056/EVIDoa2300067. Relacionado. Cavidades y válvulas del corazón · Enfermedad cardíaca congénita en adultos · Enfermedad de la ...
2023; doi:10.1056/EVIDoa2300067. ذات صلة. ارتجاع الصمام الأورطي · استبدال الصمام الأبهري عبر القسطرة (TAVR) · استبدال الصمام البيولوجي · استبدال ...
Wang TY, et al. Apixaban or warfarin in patients with an ON-X mechanical aortic valve. NEJM Evidence. 2023; doi:10.1056/EVIDoa2300067.
Apixaban or warfarin in patients with an ON-X mechanical aortic valve. NEJM Evidence. 2023; doi:10.1056/EVIDoa2300067. ذات صلة. ارتجاع الصمام ...
2023; doi:10.1056/EVIDoa2300067. Related. Aortic valve disease · Aortic valve regurgitation · Aortic valve regurgitation · Aortic valve repair ...
2023; doi:10.1056/EVIDoa2300067. Related. Aortic valve disease · Aortic valve regurgitation · Aortic valve regurgitation · Aortic valve repair ...
2023; doi:10.1056/EVIDoa2300067. Related. Aortic valve disease · Aortic valve regurgitation · Aortic valve regurgitation · Aortic valve repair ...
... patients with an On-X mechanical aortic valve. Published May 6, 2023 NEJM Evid 2023;2(7) DOI: 10.1056/EVIDoa2300067.